Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

10.1016/j.annonc.2020.03.293

Saved in:

Bibliographic Details
Main Authors:	Schuler, M, Berardi, R, Lim, W-T, de Jonge, M, Bauer, TM, Azaro, A, Gottfried, M, Han, J-Y, Lee, DH, Wollner, M, Hong, DS, Vogel, A, Delmonte, A, Akimov, M, Ghebremariam, S, Cui, X, Nwana, N, Giovannini, M, Kim, TM
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Language:	English
Published:	ELSEVIER 2024
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology capmatinib MET amplification MET exon 14 MET mutation NSCLC GENE COPY NUMBER MET AMPLIFICATION ACQUIRED-RESISTANCE MUTATIONS EGFR ONARTUZUMAB COMBINATION ACTIVATION GEFITINIB ERLOTINIB
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/248920
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-248920
record_format	dspace
spelling	sg-nus-scholar.10635-2489202024-11-11T21:41:56Z Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial Schuler, M Berardi, R Lim, W-T de Jonge, M Bauer, TM Azaro, A Gottfried, M Han, J-Y Lee, DH Wollner, M Hong, DS Vogel, A Delmonte, A Akimov, M Ghebremariam, S Cui, X Nwana, N Giovannini, M Kim, TM DUKE-NUS MEDICAL SCHOOL Assoc Prof Wan-Teck Darren Lim Science & Technology Life Sciences & Biomedicine Oncology capmatinib MET amplification MET exon 14 MET mutation NSCLC GENE COPY NUMBER MET AMPLIFICATION ACQUIRED-RESISTANCE MUTATIONS EGFR ONARTUZUMAB COMBINATION ACTIVATION GEFITINIB ERLOTINIB 10.1016/j.annonc.2020.03.293 ANNALS OF ONCOLOGY 31 6 789-797 2024-06-15T02:47:24Z 2024-06-15T02:47:24Z 2020-06 2024-06-12T14:05:34Z Article Schuler, M, Berardi, R, Lim, W-T, de Jonge, M, Bauer, TM, Azaro, A, Gottfried, M, Han, J-Y, Lee, DH, Wollner, M, Hong, DS, Vogel, A, Delmonte, A, Akimov, M, Ghebremariam, S, Cui, X, Nwana, N, Giovannini, M, Kim, TM (2020-06). Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial. ANNALS OF ONCOLOGY 31 (6) : 789-797. ScholarBank@NUS Repository. https://doi.org/10.1016/j.annonc.2020.03.293 0923-7534 1569-8041 https://scholarbank.nus.edu.sg/handle/10635/248920 en ELSEVIER Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Oncology capmatinib MET amplification MET exon 14 MET mutation NSCLC GENE COPY NUMBER MET AMPLIFICATION ACQUIRED-RESISTANCE MUTATIONS EGFR ONARTUZUMAB COMBINATION ACTIVATION GEFITINIB ERLOTINIB
spellingShingle	Science & Technology Life Sciences & Biomedicine Oncology capmatinib MET amplification MET exon 14 MET mutation NSCLC GENE COPY NUMBER MET AMPLIFICATION ACQUIRED-RESISTANCE MUTATIONS EGFR ONARTUZUMAB COMBINATION ACTIVATION GEFITINIB ERLOTINIB Schuler, M Berardi, R Lim, W-T de Jonge, M Bauer, TM Azaro, A Gottfried, M Han, J-Y Lee, DH Wollner, M Hong, DS Vogel, A Delmonte, A Akimov, M Ghebremariam, S Cui, X Nwana, N Giovannini, M Kim, TM Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial
description	10.1016/j.annonc.2020.03.293
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Schuler, M Berardi, R Lim, W-T de Jonge, M Bauer, TM Azaro, A Gottfried, M Han, J-Y Lee, DH Wollner, M Hong, DS Vogel, A Delmonte, A Akimov, M Ghebremariam, S Cui, X Nwana, N Giovannini, M Kim, TM
format	Article
author	Schuler, M Berardi, R Lim, W-T de Jonge, M Bauer, TM Azaro, A Gottfried, M Han, J-Y Lee, DH Wollner, M Hong, DS Vogel, A Delmonte, A Akimov, M Ghebremariam, S Cui, X Nwana, N Giovannini, M Kim, TM
author_sort	Schuler, M
title	Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial
title_short	Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial
title_full	Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial
title_fullStr	Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial
title_full_unstemmed	Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial
title_sort	molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase i trial
publisher	ELSEVIER
publishDate	2024
url	https://scholarbank.nus.edu.sg/handle/10635/248920
_version_	1821183683904667648

Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

Similar Items